ISEE Overview
    Upcoming Projects (ISEE)
      
  
  - 
  Don’t see a project related to the company you care about? Create your own! 
    Executed Projects (ISEE)
      
  
  - 
  Quarterly Survey: Geographic Atrophy (GA) Treatments including Apellis' Syfovre and Iveric Bio's Izervay October 2024
 Tickers: APLS, ISEE
 Executed On: Oct 22, 2024 at 11:59 AM EDT
- 
  Quarterly Survey: Geographic Atrophy (GA) Treatments including Apellis' Syfovre and Iveric Bio's Izervay July 2024
 Tickers: APLS, ISEE
 Executed On: Jul 23, 2024 at 02:12 PM EDT
- 
  Quarterly Survey: Geographic Atrophy (GA) Treatments including Apellis' Syfovre and Iveric Bio's Izervay April 2024
 Tickers: APLS, ISEE
 Executed On: Apr 18, 2024 at 03:27 PM EDT
- 
  Quarterly Survey: Geographic Atrophy (GA) Treatments including Apellis' Syfovre and Iveric Bio's Izervay January 2024
 Tickers: APLS, ISEE
 Executed On: Jan 23, 2024 at 04:40 PM EST
- 
  Quarterly Survey: Geographic Atrophy (GA) Treatments including Apellis' Syfovre and Iveric Bio's Izervay October 2023
 Tickers: APLS, ISEE
 Executed On: Oct 26, 2023 at 02:24 PM EDT
- 
  Quarterly Survey: Geographic Atrophy (GA) / Apellis' Syfovre and the impact of the Adverse Event Reports - July 2023
 Tickers: APLS, ISEE
 Executed On: Aug 01, 2023 at 03:28 PM EDT
- 
  A Third Look: Understanding the impact of 6 reported cases of inflammation in patients receiving Syfovre injections
 Tickers: APLS, ISEE
 Executed On: Jul 20, 2023 at 03:00 PM EDT
- 
  A Second Look: Understanding the impact of 6 reported cases of inflammation in patients receiving Syfovre injections
 Tickers: APLS, ISEE
 Executed On: Jul 19, 2023 at 04:00 PM EDT
- 
  Understanding the impact of 6 reported cases of inflammation in patients receiving Syfovre injections
 Tickers: APLS, ISEE
 Executed On: Jul 18, 2023 at 09:00 AM EDT
- 
  2 Week Delay: Apellis Pharmaceuticals' Pegcetacoplan GA Label and Pricing Individual Results
 Tickers: APLS, ISEE
 Executed On: Mar 13, 2023 at 05:39 PM EDT
- 
  A Second View: Digging into the topline data from Iveric Bio's Zimura GATHER2 Phase 3 Clinical Trial in Geographic Atrophy and how it compares to Apellis' EMPAVELI
 Tickers: ISEE, APLS
 Executed On: Sep 09, 2022 at 01:30 PM EDT
- 
  Digging into the topline data from Iveric Bio's Zimura GATHER2 Phase 3 Clinical Trial in Geographic Atrophy
 Tickers: ISEE, APLS
 Executed On: Sep 07, 2022 at 04:30 PM EDT
    Upcoming & Overdue Catalysts (ISEE)
      
  
  - 
  Don’t see a catalyst related to the company you care about? Create your own! 
     Strategic Initiatives (ISEE)
      
  
  - 
  Don’t see a strategic initiative related to the company you care about? Create your own! 
 
               
               
              